158 related articles for article (PubMed ID: 34326316)
1. Probing tissue transglutaminase mediated vascular smooth muscle cell aging using a novel transamidation-deficient Tgm2-C277S mouse model.
Wang H; Chen J; Jandu S; Melucci S; Savage W; Nandakumar K; Kang SK; Barreto-Ortiz S; Poe A; Rastogi S; Bauer M; Steppan J; Santhanam L
Cell Death Discov; 2021 Jul; 7(1):197. PubMed ID: 34326316
[TBL] [Abstract][Full Text] [Related]
2. Functional characterization of naturally occurring transglutaminase 2 mutants implicated in early-onset type 2 diabetes.
Salter NW; Ande SR; Nguyen HK; Nyomba BL; Mishra S
J Mol Endocrinol; 2012 Jun; 48(3):203-16. PubMed ID: 22394545
[TBL] [Abstract][Full Text] [Related]
3. Tissue Transglutaminase Modulates Vascular Stiffness and Function Through Crosslinking-Dependent and Crosslinking-Independent Functions.
Steppan J; Bergman Y; Viegas K; Armstrong D; Tan S; Wang H; Melucci S; Hori D; Park SY; Barreto SF; Isak A; Jandu S; Flavahan N; Butlin M; An SS; Avolio A; Berkowitz DE; Halushka MK; Santhanam L
J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28159817
[TBL] [Abstract][Full Text] [Related]
4. Missense mutations in the TGM2 gene encoding transglutaminase 2 are found in patients with early-onset type 2 diabetes. Mutation in brief no. 982. Online.
Porzio O; Massa O; Cunsolo V; Colombo C; Malaponti M; Bertuzzi F; Hansen T; Johansen A; Pedersen O; Meschi F; Terrinoni A; Melino G; Federici M; Decarlo N; Menicagli M; Campani D; Marchetti P; Ferdaoussi M; Froguel P; Federici G; Vaxillaire M; Barbetti F
Hum Mutat; 2007 Nov; 28(11):1150. PubMed ID: 17939176
[TBL] [Abstract][Full Text] [Related]
5. Transglutaminase 2 transamidation activity during first-phase insulin secretion: natural substrates in INS-1E.
Russo L; Marsella C; Nardo G; Massignan T; Alessio M; Piermarini E; La Rosa S; Finzi G; Bonetto V; Bertuzzi F; Maechler P; Massa O
Acta Diabetol; 2013 Feb; 50(1):61-72. PubMed ID: 22382775
[TBL] [Abstract][Full Text] [Related]
6. Canonical and truncated transglutaminase-2 regulate mucin-1 expression and androgen independency in prostate cancer cell lines.
Atobatele AG; Tonoli E; Vadakekolathu J; Savoca MP; Barr M; Kataria Y; Rossanese M; Burhan I; McArdle S; Caccamo D; Verderio EAM
Cell Death Dis; 2023 May; 14(5):317. PubMed ID: 37160910
[TBL] [Abstract][Full Text] [Related]
7. Role of Tissue Transglutaminase Catalytic and Guanosine Triphosphate-Binding Domains in Renal Cell Carcinoma Progression.
Ulukan B; Bihorac A; Sipahioglu T; Kiraly R; Fesus L; Telci D
ACS Omega; 2020 Nov; 5(43):28273-28284. PubMed ID: 33163811
[TBL] [Abstract][Full Text] [Related]
8. Transglutaminase 2 moderates the expansion of mouse abdominal aortic aneurysms.
Griffin KJ; Simpson KR; Beckers CML; Newell LM; Cheah LT; Yuldasheva NY; Iismaa S; Jackson CL; Scott JDA; Pease RJ
JVS Vasc Sci; 2021; 2():95-109. PubMed ID: 34617062
[TBL] [Abstract][Full Text] [Related]
9. The Differential Effects of R580A Mutation on Transamidation and GTP Binding Activity of Rat and Human Type 2 Transglutaminase.
Ruan Q; Tucholski J; Gundemir S; Johnson Voll GV
Int J Clin Exp Med; 2008; 1(3):248-59. PubMed ID: 19079660
[TBL] [Abstract][Full Text] [Related]
10. Transglutaminase 2 limits the extravasation and the resultant myocardial fibrosis associated with factor XIII-A deficiency.
Griffin KJ; Newell LM; Simpson KR; Beckers CML; Drinkhill MJ; Standeven KF; Cheah LT; Iismaa SE; Grant PJ; Jackson CL; Pease RJ
Atherosclerosis; 2020 Feb; 294():1-9. PubMed ID: 31874419
[TBL] [Abstract][Full Text] [Related]
11. Increased Osteoclastogenesis in Absence of TG2 Is Reversed by Transglutaminase Inhibition-Evidence for the Role for TG1 in Osteoclast Formation.
Ebrahimi Samani S; Kaartinen MT
Cells; 2023 Aug; 12(17):. PubMed ID: 37681871
[TBL] [Abstract][Full Text] [Related]
12. Cytosolic guanine nucledotide binding deficient form of transglutaminase 2 (R580a) potentiates cell death in oxygen glucose deprivation.
Colak G; Keillor JW; Johnson GV
PLoS One; 2011 Jan; 6(1):e16665. PubMed ID: 21304968
[TBL] [Abstract][Full Text] [Related]
13. Biological Implications and Functional Significance of Transglutaminase Type 2 in Nervous System Tumors.
Buccarelli M; Castellani G; Fiorentino V; Pizzimenti C; Beninati S; Ricci-Vitiani L; Scattoni ML; Mischiati C; Facchiano F; Tabolacci C
Cells; 2024 Apr; 13(8):. PubMed ID: 38667282
[TBL] [Abstract][Full Text] [Related]
14. The transglutaminase 2 gene (TGM2), a potential molecular marker for chemotherapeutic drug sensitivity, is epigenetically silenced in breast cancer.
Ai L; Kim WJ; Demircan B; Dyer LM; Bray KJ; Skehan RR; Massoll NA; Brown KD
Carcinogenesis; 2008 Mar; 29(3):510-8. PubMed ID: 18174247
[TBL] [Abstract][Full Text] [Related]
15. Inhibition or ablation of transglutaminase 2 impairs astrocyte migration.
Monteagudo A; Ji C; Akbar A; Keillor JW; Johnson GVW
Biochem Biophys Res Commun; 2017 Jan; 482(4):942-947. PubMed ID: 27899316
[TBL] [Abstract][Full Text] [Related]
16. Transglutaminase in Receptor and Neurotransmitter-Regulated Functions.
Muma NA
Med One; 2018; 3(6):. PubMed ID: 30701197
[TBL] [Abstract][Full Text] [Related]
17. Silencing of TGM2 reverses epithelial to mesenchymal transition and modulates the chemosensitivity of breast cancer to docetaxel.
He W; Sun Z; Liu Z
Exp Ther Med; 2015 Oct; 10(4):1413-1418. PubMed ID: 26622499
[TBL] [Abstract][Full Text] [Related]
18. Transglutaminase 2 promotes tumorigenicity of colon cancer cells by inactivation of the tumor suppressor p53.
Malkomes P; Lunger I; Oppermann E; Abou-El-Ardat K; Oellerich T; Günther S; Canbulat C; Bothur S; Schnütgen F; Yu W; Wingert S; Haetscher N; Catapano C; Dietz MS; Heilemann M; Kvasnicka HM; Holzer K; Serve H; Bechstein WO; Rieger MA
Oncogene; 2021 Jun; 40(25):4352-4367. PubMed ID: 34103685
[TBL] [Abstract][Full Text] [Related]
19. External GTP-bound transglutaminase 2 is a molecular switch for chondrocyte hypertrophic differentiation and calcification.
Johnson KA; Terkeltaub RA
J Biol Chem; 2005 Apr; 280(15):15004-12. PubMed ID: 15691824
[TBL] [Abstract][Full Text] [Related]
20. Distinct transglutaminase 2-independent and transglutaminase 2-dependent pathways mediate articular chondrocyte hypertrophy.
Johnson KA; van Etten D; Nanda N; Graham RM; Terkeltaub RA
J Biol Chem; 2003 May; 278(21):18824-32. PubMed ID: 12606540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
